![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Warfarin and aspirin are similar in heart failure treatment
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were...
Researchers Refine Nanoparticles For More Accurate Delivery Of Cancer Drugs
A new class of nanoparticles, synthesized by a UC Davis research team to prevent...
Mylan introduces new antiepileptic drug
Mylan Institutional business has launched Levetiracetam in Sodium Chloride Injection of multiple strengths, 500mg/100ml,...
Vidacare study reveals IO infusion equivalent to IV in Therapeutic Hypothermia
Vidacare's study to compare Intraosseous (IO) vascular access to infuse chilled saline as effectively as...
New data confirm the benefits of early and first line treatment with BetaferonĀ® in...
Bayer HealthCare announced that researchers have presented data from two international long-term follow-up studies in...
EU study shows once-daily lisdexamfetamine dimesylate (LDX) effective for symptom control in children and...
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the...
NIH researchers show how anti-HIV drug acts to block herpes virus
An anti-HIV drug also discovered to stop the spread of the genital herpes virus does...
New Study Shows CialisĀ® Significantly Improved Study Endpoints in Men
Eli Lilly and Company announced that a pivotal Phase III study of CialisĀ® (tadalafil) tablets...
Hybrigenics’ inecalcitol inhibits the growth of human hormone-dependent prostate cancer cells in vitro and...
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext in Paris, with a focus on...
New Study Released Showed Patients With Deadly Form of Lung Cancer Lived Longer Without...
Eli Lilly and Company announced that PARAMOUNT, its Phase III study evaluating ALIMTAĀ® (pemetrexed for...